About Mutilating palmoplantar keratoderma with periorificial keratotic plaques
Mutilating palmoplantar keratoderma with periorificial keratotic plaques is a rare disease catalogued by Orphanet (ORPHA:659). It is associated with the PERP, MBTPS2, TRPV3 genes. Search below for active recruiting clinical trials from ClinicalTrials.gov, or visit the Orphanet expert page for specialist centres, natural history studies, and patient registries.
Clinical Trial Eligibility Tips
What to know before applying to Mutilating palmoplantar keratoderma with periorificial keratotic plaques trials.
Search ClinicalTrials.gov for "Mutilating palmoplantar keratoderma with periorificial keratotic plaques" or filter by Orphanet code ORPHA:659 to find disease-specific studies.
Ask your specialist to refer you to a Centre of Expertise — Orphanet lists all accredited centres for this condition worldwide.
Natural history studies and patient registries often enrol before drug trials open — contact the Orphanet patient community first.
Patient Resources
Find recruiting Mutilating palmoplantar keratoderma with periorificial keratotic plaques trials
Search 500,000+ studies from ClinicalTrials.gov, filtered for Mutilating palmoplantar keratoderma with periorificial keratotic plaques. Updated daily.